Integrum AB (OSTO:INTEG B) ROCE % : 1.17% (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Integrum AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Integrum AB's annualized ROCE % for the quarter that ended in Jan. 2024 was 1.17%.

Integrum AB ROCE % Historical Data

The historical data trend for Integrum AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrum AB ROCE % Chart

Integrum AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

ROCE %

Get a 7-Day Free Trial

-135.67

-73.99

-8.21

1.30

-13.89

Integrum AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
ROCE %	Get a 7-Day Free Trial															-37.16	-24.37	-8.01	18.11	1.17

Integrum AB ROCE % Calculation

Integrum AB's annualized ROCE % for the fiscal year that ended in Apr. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Apr. 2023 )		(A: Apr. 2022 )		(A: Apr. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Apr. 2023 )		(A: Apr. 2022 )		(A: Apr. 2023 )
	=	-21.513	/	( ( (180.435 - 20.695)	+	(165.169 - 15.213) )	/ 2 )
	=	-21.513	/	( (159.74	+	149.956)	/ 2 )
	=	-21.513	/	154.848
	=	-13.89 %

Integrum AB's ROCE % of for the quarter that ended in Jan. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	1.692	/	( ( (161.917 - 18.803)	+	(166.171 - 20.52) )	/ 2 )
	=	1.692	/	( ( 143.114	+	145.651 )	/ 2 )
	=	1.692	/	144.3825
	=	1.17 %

(1) Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

Integrum AB (OSTO:INTEG B) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Integrum AB ROCE % Related Terms

Thank you for viewing the detailed overview of Integrum AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrum AB (OSTO:INTEG B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integrum AB (OSTO:INTEG B) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

6Y1:Germany

Address

Krokslatts Fabriker 50, Molndal, SWE, SE-431 37

Website

http://www.integrum.se

Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.

Integrum AB (OSTO:INTEG B) Headlines

No Headlines